Want to see INDP full AI Analyst Report?
Indaptus Therapeutics (INDP) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tislelizumab, Decoy20 | Pancreatic Adenocarcinoma, Msi-H Cancer, Solid Tumor, Adult, Uc (Urothelial Cancer), Hcc - Hepatocellular Carcinoma, Crc (Colorectal Cancer), Nsclc Non-Small Cell Lung Cancer, Squamous Cell Cancer Of The Head And Neck | phase1AndPhase2 | Recruiting | Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors | Nov 18, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tislelizumab, Decoy20 | phase1AndPhase2 | Pancreatic Adenocarcinoma, Msi-H Cancer, Solid Tumor, Adult, Uc (Urothelial Cancer), Hcc - Hepatocellular Carcinoma, Crc (Colorectal Cancer), Nsclc Non-Small Cell Lung Cancer, Squamous Cell Cancer Of The Head And Neck | Recruiting | Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors | Nov 18, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Indaptus Therapeutics, Inc. (INDP) have in its pipeline
Indaptus Therapeutics INDP is currently developing the following drugs: Tislelizumab, Decoy20. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
